What adjustments to the current fertility treatment regimen are recommended for a 30-year-old woman with primary infertility, PCOS, hyperprolactinemia, very low BMI, and empty follicles during OPU, whose male partner has low rapid motility and morphology?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Empty Follicle Syndrome: Critical Protocol Adjustments Needed

Your patient experienced empty follicle syndrome (EFS) despite adequate trigger response (LH 35 IU/L at 12 hours), and the most critical issue to address is her severely low BMI (<18 kg/m²), which should be corrected before attempting another IVF cycle. 1

Immediate Priority: Address Low BMI Before Next Cycle

  • The Endocrine Society explicitly recommends that women should have a BMI ≥18.5 kg/m² before ovulation induction is offered, as severe underweight creates a functional hypothalamic state that compromises oocyte quality and maturation 1
  • At approximately 40 kg with likely BMI <18, your patient falls into a high-risk category where energy deficit may have contributed to poor oocyte cytoplasmic maturation despite follicular growth 1
  • Weight restoration should be the first intervention, as even 5% weight gain can dramatically improve reproductive outcomes 1

The Empty Follicle Syndrome: What Went Wrong

Your protocol appeared technically sound on paper, but several factors likely contributed:

Trigger Timing and Dosing Issues

  • The dual trigger (GnRH agonist + hCG) was appropriate given the high E2 (5033 pg/mL) and PCOS diagnosis to reduce OHSS risk 1
  • However, your 12-hour post-trigger LH of 35 IU/L, while seemingly adequate, may have been insufficient for final oocyte maturation in the context of severe undernutrition 1
  • The combination of low BMI and possible functional hypothalamic component may have impaired oocyte cytoplasmic maturation despite adequate LH surge 1

Protocol Modifications for Next Cycle

After achieving BMI ≥18.5 kg/m², consider these specific adjustments:

1. Reconsider the GnRH Agonist Protocol

  • Your long luprolide protocol (0.5 mL from day 21 for 8 days) may have been excessive for a patient with borderline functional hypothalamic features 1
  • The very low BMI combined with PCOS creates a mixed picture that may respond better to an antagonist protocol, avoiding prolonged pituitary suppression 1

2. Optimize Trigger Strategy

  • For the next cycle, consider hCG-only trigger (10,000 IU) rather than dual trigger, as the GnRH agonist component requires adequate pituitary reserve that may be compromised in severe underweight 1
  • Alternatively, if using dual trigger again, check LH at both 12 and 24 hours post-trigger to ensure sustained elevation (target LH >15 IU/L at both timepoints)

3. Adjust Stimulation Approach

  • Your total FSH dose (OVUTAS HP 150 IU + Follisurge 150 IU = 300 IU daily) was reasonable for PCOS with AMH 8.6 1
  • However, the addition of Deviry (medroxyprogesterone) 10 mg twice daily during stimulation is unconventional and may have interfered with oocyte maturation - this should be discontinued in future cycles 1

Address the Male Factor Concurrently

Your partner's 12% rapid motility and 3% normal morphology indicate moderate male factor infertility requiring ICSI regardless of oocyte retrieval success 1, 2

  • The American Urological Association states that ICSI directly overcomes motility and morphology defects, making it essential for your case 1, 2
  • Antioxidants for 3 months have questionable clinical utility according to AUA/ASRM guidelines, but continuing them for another 3 months while addressing female factors is reasonable 1
  • Never prescribe testosterone to the male partner, as this will cause azoospermia 1, 2, 3

Hyperprolactinemia Management

  • Your prolactin of 31 ng/mL on cabergoline suggests inadequate suppression - normal prolactin is typically <25 ng/mL 4, 5
  • Persistent mild hyperprolactinemia (even 30-40 ng/mL) can cause luteal insufficiency and impair oocyte quality 4, 5
  • Increase cabergoline dose to achieve prolactin <20 ng/mL before the next cycle, as this significantly improves fertility outcomes 4, 5, 6

Specific Algorithm for Next Cycle

Phase 1: Preparation (3-6 months)

  1. Achieve BMI ≥18.5 kg/m² through nutritional counseling and supervised weight gain 1
  2. Optimize prolactin to <20 ng/mL by adjusting cabergoline dose 4, 5
  3. Continue male partner on antioxidants (limited evidence but low risk) 1
  4. Confirm spontaneous menstrual cycles have resumed before proceeding 1

Phase 2: Stimulation Protocol

  1. Switch to GnRH antagonist protocol (avoid prolonged suppression) 1
  2. Start with FSH 150-225 IU daily (lower than previous cycle) 1
  3. Eliminate Deviry during stimulation 1
  4. Add antagonist when lead follicle reaches 14mm 1

Phase 3: Trigger and Retrieval

  1. Use hCG 10,000 IU alone when ≥3 follicles reach 17-18mm 1
  2. Check LH at 12 and 24 hours post-trigger (target >15 IU/L both times)
  3. Perform OPU 35-36 hours post-trigger 1
  4. Plan for ICSI given male factor 1, 2

Critical Pitfalls to Avoid

  • Do not proceed with another IVF cycle until BMI ≥18.5 kg/m² - this is the single most important intervention 1
  • Do not use medroxyprogesterone during stimulation - this is not standard practice and may impair oocyte maturation 1
  • Do not assume adequate trigger based solely on 12-hour LH - consider 24-hour measurement as well
  • Do not delay ICSI - with 12% rapid motility and 3% morphology, conventional IVF will likely fail 1, 2

Alternative Consideration: Pulsatile GnRH Therapy

If weight restoration fails or the patient cannot achieve BMI ≥18.5 kg/m², consider that she may have functional hypothalamic amenorrhea with PCOM rather than true PCOS 1

  • Pulsatile GnRH therapy may be more effective than gonadotropins in this specific scenario 1
  • This requires specialized equipment and expertise but can "wake up" the hypothalamic-pituitary axis more physiologically 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment for Male Patients with Low Sperm Motility (Asthenozoospermia)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Male Infertility

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Hyperprolactinemia and infertility: new insights.

The Journal of clinical investigation, 2012

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.